The Thyroid-Stimulating Hormone Receptor: Impact of Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor Antibodies on Multimerization, Cleavage, and Signaling

Endocrinology and Metabolism Clinics of North America

Volumn 38, Issue 2, 2009, Pages 319-341

  Latif, Rauf ^a   Morshed, Syed A ^a   Zaidi, Mone ^b   Davies, Terry F ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune thyroid disease; Multimerization; Oligomerization; Signaling; TSH receptor; TSHR antibodies

Indexed keywords

THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY;

ADIPOCYTE; AUTOIMMUNE DISEASE; DISULFIDE BOND; GENE EXPRESSION; GENE MUTATION; GLYCOSYLATION; HORMONE STRUCTURE; HUMAN; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; REVIEW; SULFATION; THYROID DISEASE;

ANIMALS; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, THYROTROPIN; SIGNAL TRANSDUCTION; THYROIDITIS, AUTOIMMUNE; THYROTROPIN;

EID: 62749104387     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2009.01.006     Document Type: Review

References (128)

1. Rapoport B., Chazenbalk G.D., Jaume J.C., et al. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 19 (1998) 673-716
2. Misrahi M., Loosfelt H., Atger M., et al. Cloning, sequencing and expression of human TSH receptor. Biochem Biophys Res Commun 166 (1990) 394-403
3. Nagayama Y., Kaufman K.D., Seto P., et al. Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun 165 (1989) 1184-1190
4. Parmentier M., Libert F., Maenhaut C., et al. Molecular cloning of the thyrotropin receptor. Science 246 (1989) 1620-1622
5. De Felice M., Postiglione M.P., and Di Lauro R. Minireview: thyrotropin receptor signaling in development and differentiation of the thyroid gland: insights from mouse models and human diseases. Endocrinology 145 (2004) 4062-4067
6. Postiglione M.P., Parlato R., Rodriguez-Mallon A., et al. Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. Proc Natl Acad Sci U S A 99 (2002) 15462-15467
7. Marians R.C., Ng L., Blair H.C., et al. Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc Natl Acad Sci U S A 99 (2002) 15776-15781
8. Brown R.S. Minireview: developmental regulation of thyrotropin receptor gene expression in the fetal and newborn thyroid. Endocrinology 145 (2004) 4058-4061
9. Burrow G.N., Fisher D.A., and Larsen P.R. Maternal and fetal thyroid function. N Engl J Med 331 (1994) 1072-1078
10. Davies T.F., Ando T., Lin R.Y., et al. Thyrotropin receptor-associated diseases: from adenomata to Graves disease. J Clin Invest 115 (2005) 1972-1983
11. Thomas D., Friedman S., and Lin R.Y. Thyroid stem cells: lessons from normal development and thyroid cancer. Endocr Relat Cancer 15 (2008) 51-58
12. Bahn R.S., Dutton C.M., Natt N., et al. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy. J Clin Endocrinol Metab 83 (1998) 998-1002
13. Davies T., Marians R., and Latif R. The TSH receptor reveals itself. J Clin Invest 110 (2002) 161-164
14. Vizek K., Razova M., and Melichar V. Lipolytic effect of TSH, glucagon and hydrocortisone on the adipose tissue of newborns and adults in vitro. Physiol Bohemoslov 28 (1979) 325-331
15. Daumerie C., Ludgate M., Costagliola S., et al. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. Eur J Endocrinol 146 (2002) 35-38
16. Lu M., and Lin R.Y. TSH stimulates adipogenesis in mouse embryonic stem cells. J Endocrinol 196 (2008) 159-169
17. Zhang L., Baker G., Janus D., et al. Biological effects of thyrotropin receptor activation on human orbital preadipocytes. Invest Ophthalmol Vis Sci 47 (2006) 5197-5203
18. Cawthorn W.P., and Sethi J.K. TNF-alpha and adipocyte biology. FEBS Lett 582 (2008) 117-131
19. Abe E., Marians R.C., Yu W., et al. TSH is a negative regulator of skeletal remodeling. Cell 115 (2003) 151-162
20. Abe E., Sun L., Mechanick J., et al. Bone loss in thyroid disease: role of low TSH and high thyroid hormone. Ann N Y Acad Sci 1116 (2007) 383-391
21. Sun L., Vukicevic S., Baliram R., et al. Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss. Proc Natl Acad Sci U S A 105 (2008) 4289-4294
22. Bassett J.H., Williams A.J., Murphy E., et al. A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism. Mol Endocrinol 22 (2008) 501-512
23. Stassi G., and De M.R. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol 2 (2002) 195-204
24. Ando T., Latif R., Pritsker A., et al. A monoclonal thyroid-stimulating antibody. J Clin Invest 110 (2002) 1667-1674
25. Costagliola S., Franssen J.D., Bonomi M., et al. Generation of a mouse monoclonal TSH receptor antibody with stimulating activity. Biochem Biophys Res Commun 299 (2002) 891-896
26. Sanders J., Jeffreys J., Depraetere H., et al. Thyroid-stimulating monoclonal antibodies. Thyroid 12 (2002) 1043-1050
27. Ando T., Latif R., and Davies T.F. Concentration-dependent regulation of thyrotropin receptor function by thyroid-stimulating antibody. J Clin Invest 113 (2004) 1589-1595
28. Latif R., Graves P., and Davies T.F. Oligomerization of the human thyrotropin receptor: fluorescent protein-tagged hTSHR reveals post-translational complexes. J Biol Chem 276 (2001) 45217-45224
29. Libert F., Lefort A., Gerard C., et al. Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem Biophys Res Commun 165 (1989) 1250-1255
30. Kajita Y., Rickards C.R., Buckland P.R., et al. Analysis of thyrotropin receptors by photoaffinity labelling. Orientation of receptor subunits in the cell membrane. Biochem J 227 (1985) 413-420
31. Loosfelt H., Pichon C., Jolivet A., et al. Two-subunit structure of the human thyrotropin receptor. Proc Natl Acad Sci U S A 89 (1992) 3765-3769
32. Vlaeminck-Guillem V., Ho S.C., Rodien P., et al. Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol Endocrinol 16 (2002) 736-746
33. Neumann S., Claus M., and Paschke R. Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation. Eur J Endocrinol 152 (2005) 625-634
34. Claus M., Jaeschke H., Kleinau G., et al. A hydrophobic cluster in the center of the third extracellular loop is important for thyrotropin receptor signaling. Endocrinology 146 (2005) 5197-5203
35. Fan Q.R., and Hendrickson W.A. Structure of human follicle-stimulating hormone in complex with its receptor. Nature 433 (2005) 269-277
36. Moyle W.R., Xing Y., Lin W., et al. Model of glycoprotein hormone receptor ligand binding and signaling. J Biol Chem 279 (2004) 44442-44459
37. Nunez M.R., Sanders J., Jeffreys J., et al. Analysis of the thyrotropin receptor-thyrotropin interaction by comparative modeling. Thyroid 14 (2004) 991-1011
38. Mizutori Y., Chen C.R., McLachlan S.M., et al. The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction. Mol Endocrinol 22 5 (2008) 1171-1182
39. Claus M., Neumann S., Kleinau G., et al. Structural determinants for G-protein activation and specificity in the third intracellular loop of the thyroid-stimulating hormone receptor. J Mol Med 84 (2006) 943-954
40. Neumann S., Krause G., Claus M., et al. Structural determinants for G protein activation and selectivity in the second intracellular loop of the thyrotropin receptor. Endocrinology 146 (2005) 477-485
41. Wadsworth H.L., Chazenbalk G.D., Nagayama Y., et al. An insertion in the human thyrotropin receptor critical for high affinity hormone binding. Science 249 (1990) 1423-1425
42. Chazenbalk G.D., Nagayama Y., Russo D., et al. Functional analysis of the cytoplasmic domains of the human thyrotropin receptor by site-directed mutagenesis. J Biol Chem 265 (1990) 20970-20975
43. Wadsworth H.L., Russo D., Nagayama Y., et al. Studies on the role of amino acids 38-45 in the expression of a functional thyrotropin receptor. Mol Endocrinol 6 (1992) 394-398
44. Graves P.N., and Davies T.F. New insights into the thyroid-stimulating hormone receptor. The major antigen of Graves' disease. Endocrinol Metab Clin North Am 29 (2000) 267-286 vi
45. Nagayama Y., Russo D., Wadsworth H.L., et al. Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding. J Biol Chem 266 (1991) 14926-14930
46. Smits G., Campillo M., Govaerts C., et al. Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO J 22 (2003) 2692-2703
47. Jeffreys J., Depraetere H., Sanders J., et al. Characterization of the thyrotropin binding pocket. Thyroid 12 (2002) 1051-1061
48. Nagayama Y., Wadsworth H.L., Russo D., et al. Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors. J Clin Invest 88 (1991) 336-340
49. Sanders J., Miguel R.N., Bolton J., et al. Molecular interactions between the TSH receptor and a thyroid-stimulating monoclonal autoantibody. Thyroid 17 (2007) 699-706
50. Sanders J., Chirgadze D.Y., Sanders P., et al. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 17 (2007) 395-410
51. Latif R., Graves P., and Davies T.F. Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor. J Biol Chem 277 (2002) 45059-45067
52. Ando T., Latif R., and Davies T.F. Antibody-induced modulation of TSH receptor post-translational processing. J Endocrinol 195 (2007) 179-186
53. Kursawe R., and Paschke R. Modulation of TSHR signaling by posttranslational modifications. Trends Endocrinol Metab 18 (2007) 199-207
54. Misrahi M., Ghinea N., Sar S., et al. Processing of the precursors of the human thyroid-stimulating hormone receptor in various eukaryotic cells (human thyrocytes, transfected L cells and baculovirus-infected insect cells). Eur J Biochem 222 (1994) 711-719
55. Tanaka K., Chazenbalk G.D., McLachlan S.M., et al. Subunit structure of thyrotropin receptors expressed on the cell surface. J Biol Chem 274 (1999) 33979-33984
56. Nagayama Y., Nishihara E., Namba H., et al. Identification of the sites of asparagine-linked glycosylation on the human thyrotropin receptor and studies on their role in receptor function and expression. J Pharmacol Exp Ther 295 (2000) 404-409
57. Costagliola S., Panneels V., Bonomi M., et al. Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO J 21 (2002) 504-513
58. Bonomi M., Busnelli M., Persani L., et al. Structural differences in the hinge region of the glycoprotein hormone receptors: evidence from the sulfated tyrosine residues. Mol Endocrinol 20 (2006) 3351-3363
59. Kosugi S., and Mori T. Cysteine-699, a possible palmitoylation site of the thyrotropin receptor, is not crucial for cAMP or phosphoinositide signaling but is necessary for full surface expression. Biochem Biophys Res Commun 221 (1996) 636-640
60. Latif R., Michalek C., Morshed S., et al. Dimerization of the TSH receptor ectodomain. [abstract] (2007)
61. Breitwieser G.E. G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling. Circ Res 94 (2004) 17-27
62. Graves P.N., Vlase H., Bobovnikova Y., et al. Multimeric complex formation by the thyrotropin receptor in solubilized thyroid membranes. Endocrinology 137 (1996) 3915-3920
63. Vlase H., Graves P.N., Magnusson R.P., et al. Human autoantibodies to the thyrotropin receptor: recognition of linear, folded, and glycosylated recombinant extracellular domain. J Clin Endocrinol Metab 80 (1995) 46-53
64. Ban T., Kosugi S., and Kohn L.D. Specific antibody to the thyrotropin receptor identifies multiple receptor forms in membranes of cells transfected with wild-type receptor complementary deoxyribonucleic acid: characterization of their relevance to receptor synthesis, processing, structure, and function. Endocrinology 131 (1992) 815-829
65. Graves P.N., Vlase H., Bobovnikova Y., et al. Multimeric complex formation by the natural TSH receptor. Endocrinology 137 (1996) 3915-3920
66. Grossman R.F., Ban T., Duh Q.Y., et al. Immunoprecipitation isolates multiple TSH receptor forms from human thyroid tissue. Thyroid 5 (1995) 101-105
67. Urizar E., Montanelli L., Loy T., et al. Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO J 24 (2005) 1954-1964
68. Persani L., Calebiro D., and Bonomi M. Technology insight: modern methods to monitor protein-protein interactions reveal functional TSH receptor oligomerization. Nat Clin Pract Endocrinol Metab 3 (2007) 180-190
69. Park P.S., Filipek S., Wells J.W., et al. Oligomerization of G protein-coupled receptors: past, present, and future. Biochemistry 43 (2004) 15643-15656
70. Calebiro D., de F.T., Lucchi S., et al. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance. Hum Mol Genet 14 (2005) 2991-3002
71. Latif R., Ando T., Daniel S., et al. Localization and regulation of thyrotropin receptors within lipid rafts. Endocrinology 144 (2003) 4725-4728
72. Latif R., Ando T., and Davies T.F. Lipid rafts are triage centers for multimeric and monomeric thyrotropin receptor regulation. Endocrinology 148 (2007) 3164-3175
73. Chazenbalk G.D., Tanaka K., Nagayama Y., et al. Evidence that the TSH receptor ectodomain contains not one, but two, cleavage sites. Endocrinology 138 (1997) 2893-2899
74. Misrahi M., and Milgrom E. Cleavage and shedding of the TSH receptor. Eur J Endocrinol 137 (1997) 599-602
75. Couet J., Sar S., Jolivet A., et al. Shedding of human TSH receptor ectodomain: involvement of a matrix metalloprotease. J Biol Chem 271 (1996) 4545-4552
76. de Bernard S., Misrahi M., Huet J.C., et al. Sequential cleavage and excision of a segment of the thyrotropin receptor ectodomain. J Biol Chem 274 (1999) 101-107
77. Kaczur V., Puskas L.G., Nagy Z.U., et al. Cleavage of the human thyrotropin receptor by ADAM10 is regulated by thyrotropin. J Mol Recognit 20 (2007) 392-404
78. Couet J., de Bernard S., Loosfelt H., et al. Cell surface protein disulfide-isomerase is involved in the shedding of human thyrotropin receptor ectodomain. Biochemistry 35 (1996) 14800-14805
79. Couet J., Sar S., Jolivet A., et al. Shedding of human thyrotropin receptor ectodomain Involvement of a matrix metalloprotease. J Biol Chem 271 8 (1996) 4545-4552
80. Chen C.R., Chazenbalk G.D., Wawrowsky K.A., et al. Evidence that human thyroid cells express uncleaved, single-chain thyrotropin receptors on their surface. Endocrinology 147 (2006) 3107-3113
81. Latif R., Ando T., and Davies T.F. Monomerization as a prerequisite for intramolecular cleavage and shedding of the thyrotropin receptor. Endocrinology 145 (2004) 5580-5588
82. Vassart G., and Costagliola S. A physiological role for the posttranslational cleavage of the thyrotropin receptor?. Endocrinology 145 (2004) 1-3
83. Ciullo I., Latif R., Graves P., et al. Functional assessment of the thyrotropin receptor-beta subunit. Endocrinology 144 (2003) 3176-3181
84. Quellari M., Desroches A., Beau I., et al. Role of cleavage and shedding in human thyrotropin receptor function and trafficking. Eur J Biochem 270 (2003) 3486-3497
85. Allgeier A., Offermanns S., Van Sande J., et al. The human thyrotropin receptor activates G-proteins Gs and Gq/11. J Biol Chem 269 (1994) 13733-13735
86. Kimura T., Van K.A., Golstein J., et al. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev 22 (2001) 631-656
87. Van S.J., Massart C., Costagliola S., et al. Specific activation of the thyrotropin receptor by trypsin. Mol Cell Endocrinol 119 (1996) 161-168
88. Vassart G., Pardo L., and Costagliola S. A molecular dissection of the glycoprotein hormone receptors. Trends Biochem Sci 29 (2004) 119-126
89. Szkudlinski M.W., Fremont V., Ronin C., et al. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol Rev 82 (2002) 473-502
90. Zhang M., Tong K.P., Fremont V., et al. The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design. Endocrinology 141 (2000) 3514-3517
91. Marshall C.J. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr Opin Genet Dev 4 (1994) 82-89
92. Dremier S., Milenkovic M., Blancquaert S., et al. Cyclic AMP-dependent protein kinases, but not Epac, mediate TSH/cyclic AMP-dependent regulation of thyroid cells. Endocrinology 148 10 (2007) 4612-4622
93. Frodin M., and Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 151 (1999) 65-77
94. Stoyanov B., Volinia S., Hanck T., et al. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269 (1995) 690-693
95. Kasri N.N., Holmes A.M., Bultynck G., et al. Regulation of InsP3 receptor activity by neuronal Ca2+-binding proteins. EMBO J 23 (2004) 312-321
96. Toker A., and Newton A.C. Cellular signaling: pivoting around PDK-1. Cell 103 (2000) 185-188
97. Balendran A., Hare G.R., Kieloch A., et al. Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms. FEBS Lett 484 (2000) 217-223
98. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10 (1998) 262-267
99. Downward J. Signal transduction. New exchange, new target. Nature 396 (1998) 416-417
100. Williams M.R., Arthur J.S., Balendran A., et al. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr Biol 10 (2000) 439-448
101. Zaballos M.A., Garcia B., and Santisteban P. G{beta}{gamma} dimers released in response to TSH activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells. Mol Endocrinol 22 5 (2008) 1183-1199
102. Cao X., Kambe F., and Seo H. Requirement of thyrotropin-dependent complex formation of protein kinase A catalytic subunit with inhibitor of {kappa}B proteins for activation of p65 nuclear factor-{kappa}B by tumor necrosis factor-{alpha}. Endocrinology 146 (2005) 1999-2005
103. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12 (1994) 141-179
104. Iacovelli L., Capobianco L., Salvatore L., et al. Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP-dependent protein kinase A-independent mechanism. Mol Pharmacol 60 (2001) 924-933
105. Park Y.J., Park E.S., Kim M.S., et al. Involvement of the protein kinase C pathway in thyrotropin-induced STAT3 activation in FRTL-5 thyroid cells. Mol Cell Endocrinol 194 (2002) 77-84
106. Schmelzle T., and Hall M.N. TOR, a central controller of cell growth. Cell 103 (2000) 253-262
107. Brewer C., Yeager N., and Di C.A. Thyroid-stimulating hormone initiated proliferative signals converge in vivo on the mTOR kinase without activating AKT. Cancer Res 67 (2007) 8002-8006
108. Tomer Y., and Davies T.F. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 24 (2003) 694-717
109. Rees Smith B., McLachlan S.M., and Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr Rev 9 (1988) 106-121
110. Ando T., Latif R., and Davies T.F. Thyrotropin receptor antibodies: new insights into their actions and clinical relevance. Best Pract Res Clin Endocrinol Metab 19 (2005) 33-52
111. Kim W.B., Chung H.K., Park Y.J., et al. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease. Thyroid 10 (2000) 579-586
112. Atger M., Misrahi M., Young J., et al. Autoantibodies interacting with purified native thyrotropin receptor. Eur J Biochem 265 (1999) 1022-1031
113. Weetman A.P., Yateman M.E., Ealey P.A., et al. Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. J Clin Invest 86 (1990) 723-727
114. Zakarija M. Immunochemical characterization of the thyroid-stimulating antibody (TSAb) of Graves' disease: evidence for restricted heterogeneity. J Clin Lab Immunol 10 (1983) 77-85
115. Metcalfe R., Jordan N., Watson P., et al. Demonstration of immunoglobulin G, A, and E autoantibodies to the human thyrotropin receptor using flow cytometry. J Clin Endocrinol Metab 87 (2002) 1754-1761
116. Sanders J., Evans M., Premawardhana L.D., et al. Human monoclonal thyroid stimulating autoantibody. Lancet 362 (2003) 126-128
117. Smith B.R., Sanders J., and Furmaniak J. TSH receptor antibodies. Thyroid 17 (2007) 923-938
118. Costagliola S., Bonomi M., Morgenthaler N.G., et al. Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity. Mol Endocrinol 18 (2004) 3020-3034
119. Minich W.B., Lenzner C., and Morgenthaler N.G. Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor. Clin Exp Immunol 136 (2004) 129-136
120. Ando T., Imaizumi M., Graves P., et al. Induction of thyroid-stimulating hormone receptor autoimmunity in hamsters. Endocrinology 144 (2003) 671-680
121. Ando T., Latif R., Daniel S., et al. Dissecting linear and conformational epitopes on the native thyrotropin receptor. Endocrinology 145 (2004) 5185-5193
122. Nagayama Y., Kita-Furuyama M., Ando T., et al. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor. J Immunol 168 (2002) 2789-2794
123. Schwarz-Lauer L., Pichurin P.N., Chen C.R., et al. The cysteine-rich amino terminus of the thyrotropin receptor is the immunodominant linear antibody epitope in mice immunized using naked deoxyribonucleic acid or adenovirus vectors. Endocrinology 144 (2003) 1718-1725
124. Morshed S.A., Latif R., and Davies T.F. Characterization of thyrotropin receptor antibody-induced signaling cascades. Endocrinology 150 1 (2009) 519-529
125. Gilbert J.A., Gianoukakis A.G., Salehi S., et al. Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways. J Immunol 176 (2006) 5084-5092
126. Ando T., and Davies T.F. Monoclonal antibodies to the thyrotropin receptor. Clin Dev Immunol 12 (2005) 137-143
127. Costagliola S., Rodien P., Many M.C., et al. Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. J Immunol 160 (1998) 1458-1465
128. Chen C.R., McLachlan S.M., and Rapoport B. Suppression of thyrotropin receptor constitutive activity by a monoclonal antibody with inverse agonist activity. Endocrinology 148 (2007) 2375-2382